Trial Profile
A randomized controlled clinical study of Pramipexole for Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2012
Price :
$35
*
At a glance
- Drugs Pramipexole (Primary) ; Levodopa/benserazide; Trihexyphenidyl
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Actual end date changed from 31 Mar 2009 to 1 Nov 2009 as reported by Chinese Clinical Trial Register.
- 01 Jan 2011 New trial record